Alpharma Company Profile

✉ Email this page to a colleague

ALPHARMA has sixty-three approved drugs.

There are nine US patents protecting ALPHARMA drugs.

There are fifty-five patent family members on ALPHARMA drugs in twenty-three countries and seven supplementary protection certificates in three countries.

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009		DISCN	Yes	No	8,846,104	⤷ Subscribe	Y			⤷ Subscribe
Alpharma Us Pharms	TRIMETH/SULFA	sulfamethoxazole; trimethoprim	SUSPENSION;ORAL	072398-001	May 23, 1988		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	ERYTHROMYCIN	erythromycin	SOLUTION;TOPICAL	062327-001	Apr 19, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	CREAM;VAGINAL	087864-001	Sep 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	CREAM;TOPICAL	088361-001	Jan 16, 1984		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	TETRACYCLINE HYDROCHLORIDE	tetracycline hydrochloride	SUSPENSION;ORAL	060633-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-003	Aug 13, 2009	5,202,128	⤷ Subscribe
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-005	Aug 13, 2009	5,202,128	⤷ Subscribe
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-005	Aug 13, 2009	5,378,474	⤷ Subscribe
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-001	Aug 13, 2009	5,202,128	⤷ Subscribe
Alpharma Pharms	EMBEDA	morphine sulfate; naltrexone hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	022321-002	Aug 13, 2009	5,202,128	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Capsules	30 mg/1.2 mg, 50 mg/2 mg and 80 mg/3.2 mg	➤ Subscribe	2010-05-28
➤ Subscribe	Extended-release Capsules	100 mg/4 mg	➤ Subscribe	2010-05-03
➤ Subscribe	Extended-release Capsules	60 mg/2.4 mg	➤ Subscribe	2010-05-25

Subscribe to access the full database, or Subscribe
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1429780	13C0012	France	⤷ Subscribe	PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808
1429780	SPC/GB12/058	United Kingdom	⤷ Subscribe	PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
0809498	10C0038	France	⤷ Subscribe	PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
2233112	132014902285293	Italy	⤷ Subscribe	PRODUCT NAME: FLUOCINOLONE ACETONIDE(ILUVIEN); AUTHORISATION NUMBER(S) AND DATE(S): 042616019, 20140530;PL27813/0001, 20120504
0428296	SPC/GB98/013	United Kingdom	⤷ Subscribe	PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
1581193	SPC/GB12/047	United Kingdom	⤷ Subscribe	PRODUCT NAME: DEXAMETHASONE; REGISTERED: UK EU/1/10/638/001 20100727
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.